Results 161 to 170 of about 3,617 (206)

Associations of cardiovascular-kidney-metabolic syndrome stages with long-term mortality among US cancer survivors: a prospective cohort study. [PDF]

Cardiooncology
Zheng Y, Li T, Song J.
europepmc   +1 more source

The Prognostic Significance of Functional Mitral Regurgitation in Patients with Cardiovascular-Kidney-Metabolic Syndrome. [PDF]

J Clin Med
Du H, Chen Y, Huang C, Hu B, Wang Z, Shao S, Bao Q, Suo Y.   +7 more
europepmc   +1 more source

Sweet relief: exploring mechanisms and therapeutic approaches of sodium-glucose cotransporter-2 inhibitors in cardiovascular-kidney metabolic syndrome. [PDF]

Cardiovasc Diabetol
Hua J, Wang Q, Liu Y, Luo S, Shi A, Yan Z, Zhang J, Gu W, Zhu L, Zhang Y, Zhang L, Yu P, Liu X, Wang W.   +13 more
europepmc   +1 more source

Association Between NHHR and Future Cardiovascular Disease Among Patients With CKM Stages 0-3: A Nationwide Prospective Cohort Study. [PDF]

J Clin Hypertens (Greenwich)
Huang Y, Gao Y, Shao J, Wang K, Ma Y, Ai L, Yu J.   +6 more
europepmc   +1 more source

Association Between Depressive Symptoms and Incidence of Stroke in a Population With Cardiovascular-Kidney-Metabolic Syndrome Stages 0 to 3: Nationwide Prospective Cohort Study.

Interact J Med Res
Li Y, Wang L, Gao L.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review

Current Problems in Cardiology
The correlation between obesity, type 2 diabetes mellitus (DM), cardiovascular disease (CVD), and chronic kidney disease (CKD) is an escalating and widely acknowledged epidemic in industrialized nations. Recently, this complex web of interrelated health conditions has been collectively defined as the Cardiovascular-Kidney-Metabolic (CKM) syndrome by ...
Sneha Annie Sebastian, Inderbir Padda, Gurpreet Johal   +2 more
openaire   +4 more sources

A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association

Circulation, 2023
A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led to the conceptualization of cardiovascular-kidney-metabolic syndrome.
Chiadi E, Ndumele, Ian J, Neeland, Katherine R, Tuttle, Sheryl L, Chow, Roy O, Mathew, Sadiya S, Khan, Josef, Coresh, Carissa M, Baker-Smith, Mercedes R, Carnethon, Jean-Pierre, Després, Jennifer E, Ho, Joshua J, Joseph, Walter N, Kernan, Amit, Khera, Mikhail N, Kosiborod, Carolyn L, Lekavich, Eldrin F, Lewis, Kevin B, Lo, Bige, Ozkan, Latha P, Palaniappan, Sonali S, Patel, Michael J, Pencina, Tiffany M, Powell-Wiley, Laurence S, Sperling, Salim S, Virani, Jackson T, Wright, Radhika, Rajgopal Singh, Mitchell S V, Elkind, Janani, Rangaswami   +28 more
openaire   +4 more sources

Cumulative Incidence of Mortality Associated with Cardiovascular–Kidney–Metabolic (CKM) Syndrome

Journal of the American Society of Nephrology
Key Points Cardiovascular–kidney–metabolic (CKM) syndrome stages 1–4 were associated with a graded risk of cardiovascular mortality in a nationally representative sample of US adults.
Sophie E. Claudel, Insa M. Schmidt, Sushrut S. Waikar, Ashish Verma   +3 more
openaire   +4 more sources

Cardiovascular-Kidney-Metabolic (CKM) Syndrome: Prevalence, Risks, Disease Trajectories, and Early-Stage Management

American Journal of Physiology-Cell Physiology
Cardiovascular-Kidney-Metabolic (CKM) syndrome affects approximately 90% of US adults, arising from the convergence of metabolic dysfunction, chronic kidney disease (CKD), and cardiovascular disease (CVD). These conditions create self-reinforcing cycles of multi-organ damage, substantially increasing mortality risk.
Sophie Gunnarsson, Ortensia Vito, Robert J. Unwin   +2 more
openaire   +1 more source

Abstract 4361892: CKD and CKM Syndrome: Accelerated Progression to Arrhythmias in a National Cohort

Circulation
Introduction: Chronic kidney disease (CKD), a key element of the AHA Cardiovascular-Kidney-Metabolic (CKM) framework, is increasingly recognized as an independent risk factor for arrhythmias, especially atrial fibrillation (AF).
Pierantonio Russo, Ramaa Nathan, Jason Poh, Harjeet Singh, Ken Boyle, Brent Wright, Erik Hendrickson   +6 more
openaire   +1 more source